Literature DB >> 11788238

The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study.

Michael Ritsner1, Alexander Ponizovsky, Jean Endicott, Yakov Nechamkin, Boris Rauchverger, Henry Silver, Ilan Modai.   

Abstract

This study compared the impact of side-effects of antipsychotic treatment, clinical and psychosocial factors on the subjective quality of life (QOL) of hospitalized patients. We surveyed 161 patients meeting DSM-IV criteria for schizophrenia stabilized on conventional and atypical antipsychotic drugs using standardized measures of adverse events, psychopathology, psychosocial variables, and perceived QOL. We found that patients with adverse events reported less satisfaction with life domains of subjective feelings and general activities than asymptomatic patients. Patients treated with conventional and novel antipsychotic agents had comparable QOL ratings. Multiple regression analysis showed total variance in QOL ratings as follows: psychosocial factors, 20.9%; clinical symptoms and associated distress, 10.1%; adverse effects, 3.2%. Thus, medication side-effects influence subjective quality of life of schizophrenia inpatients significantly less than other clinical and psychosocial factors. Patient's subjective response to these events rather than their number is more predictive of QOL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788238     DOI: 10.1016/s0924-977x(01)00128-6

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  22 in total

1.  Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorder II. Predictive value of psychosocial factors.

Authors:  Michael S Ritsner; Marina Arbitman; Alexander Lisker; Alexander M Ponizovsky
Journal:  Qual Life Res       Date:  2011-10-02       Impact factor: 4.147

2.  Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients.

Authors:  Michael Ritsner; Rena Kurs; Anatoly Gibel; Yael Ratner; Jean Endicott
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

3.  Subjective quality of life of community living Sudanese psychiatric patients: comparison with family caregivers' impressions and control group.

Authors:  A W Awadalla; J U Ohaeri; A A Salih; A M Tawfiq
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

4.  Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls.

Authors:  Rena Kurs; Herman Farkas; Michael Ritsner
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

5.  Determinants of changes in perceived quality of life in the course of schizophrenia.

Authors:  Michael Ritsner; Anatoly Gibel; Yael Ratner
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

6.  Ten-year quality of life outcomes among patients with schizophrenia and schizoaffective disorders: I. Predictive value of disorder-related factors.

Authors:  Michael S Ritsner; Alexander Lisker; Marina Arbitman
Journal:  Qual Life Res       Date:  2011-09-13       Impact factor: 4.147

7.  A model of subjective quality of life for outpatients with schizophrenia and other psychoses.

Authors:  Mona Eklund; Martin Bäckström
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

8.  Neuroticism, Side Effects, and Health Perceptions Among HIV-Infected Individuals on Antiretroviral Medications.

Authors:  Mallory O Johnson; Torsten B Neilands
Journal:  J Clin Psychol Med Settings       Date:  2007-03

9.  Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients.

Authors:  Yu-Tao Xiang; Yong-Zhen Weng; Chi-Ming Leung; Wai-Kwong Tang; Kelly Y C Lai; Gabor S Ungvari
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

10.  Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study.

Authors:  H J Cho; M Kivimäki; J E Bower; M R Irwin
Journal:  Psychol Med       Date:  2012-11-14       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.